Nabumetone and Emphysema - a phase IV clinical study of FDA data

Summary:

Emphysema is reported as a side effect among people who take Nabumetone (nabumetone), especially for people who are male, 30-39 old, also take Prednisone, and have Osteoporosis.

The phase IV clinical study analyzes which people have Emphysema when taking Nabumetone. It is created by eHealthMe based on reports of 9,121 people who have side effects when taking Nabumetone from the FDA, and is updated regularly.

What is Nabumetone?

Nabumetone has active ingredients of nabumetone. It is often used in arthritis. eHealthMe is studying from 9,554 Nabumetone users. Check the latest studies of Nabumetone.

What is Emphysema?

Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs) is found to be associated with 1,062 drugs and 1,100 conditions by eHealthMe. Check the latest studies of Emphysema.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

9,121 people reported to have side effects when taking Nabumetone.
Among them, 25 people (0.27%) have Emphysema.

Among these 25 people:

What is the gender of people who have Emphysema when taking Nabumetone? *

female: 24 %
male: 76 %

What is the age of people who have Emphysema when taking Nabumetone? *

What are other drugs people take besides Nabumetone? *

What are other side effects people have besides Emphysema? *

Back Pain: 18 people, 72.00%
Intervertebral Disc Protrusion (spinal disc protrusion): 17 people, 68.00%
The Flu (the flu is caused by an influenza virus): 17 people, 68.00%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 17 people, 68.00%
Pain In Extremity: 16 people, 64.00%
Wound Dehiscence (a surgical incision reopens either internally or externally): 16 people, 64.00%
Gingival Bleeding (bleeding gums): 15 people, 60.00%
Back Disorder: 15 people, 60.00%
Gait Disturbance: 15 people, 60.00%
Osteonecrosis Of Jaw (death of bone of jaw): 15 people, 60.00%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 15 people, 60.00%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 20.00%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 1 person, 4.00%
Type 2 Diabetes: 1 person, 4.00%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 4.00%
Joint Pain: 1 person, 4.00%
Hypersensitivity: 1 person, 4.00%
High Blood Pressure: 1 person, 4.00%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 1 person, 4.00%
Diarrhea: 1 person, 4.00%

* Approximation only. Some reports may have incomplete information.

Do you take Nabumetone and have Emphysema?

- Check whether Emphysema is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nabumetone:

Nabumetone (9,554 reports)

Emphysema treatments and more:

Emphysema (29,685 reports)

Browse all side effects of Nabumetone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Emphysema:

Emphysema (1,062 drugs)

Browse all the conditions that are associated with Emphysema:

Emphysema (1,100 conditions)

Related publications that referenced our studies

Hung SC, Liao KF, Hung HC, Lin CL, Lai SW, Lin CH, "Nabumetone use and risk of acute pancreatitis in a case-control study", Pancreatology, 2016 Jun .
Hung SC, Liao KF, Hung HC, Lin CL, Lai SW, Lin CH, "Nabumetone use and risk of acute pancreatitis in a case-control study", Pancreatology, 2016 Jun .

How the study uses the data?

The study uses data from the FDA. It is based on nabumetone (the active ingredients of Nabumetone) and Nabumetone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.